Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTs.

Rossi S, Gasparotto D, Cacciatore M, Sbaraglia M, Mondello A, Polano M, Mandolesi A, Gronchi A, Reuss DE, von Deimling A, Maestro R, Dei Tos AP.

Mod Pathol. 2018 Jan;31(1):160-168. doi: 10.1038/modpathol.2017.105. Epub 2017 Sep 1.

PMID:
28862263
2.

Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.

Gasparotto D, Rossi S, Polano M, Tamborini E, Lorenzetto E, Sbaraglia M, Mondello A, Massani M, Lamon S, Bracci R, Mandolesi A, Frate E, Stanzial F, Agaj J, Mazzoleni G, Pilotti S, Gronchi A, Dei Tos AP, Maestro R.

Clin Cancer Res. 2017 Jan 1;23(1):273-282. doi: 10.1158/1078-0432.CCR-16-0152. Epub 2016 Jul 7.

3.

Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.

Rossi S, Sbaraglia M, Dell'Orto MC, Gasparotto D, Cacciatore M, Boscato E, Carraro V, Toffolatti L, Gallina G, Niero M, Pilozzi E, Mandolesi A, Sessa F, Sonzogni A, Mancini C, Mazzoleni G, Romeo S, Maestro R, Dei Tos AP.

Oncotarget. 2016 May 24;7(21):30109-18. doi: 10.18632/oncotarget.8768.

4.

Morphologic shift associated with aberrant cytokeratin expression in a GIST patient after tyrosine kinase inhibitors therapy. A case report with a brief review of the literature.

Canzonieri V, Gasparotto D, Alessandrini L, Miolo G, Torrisi E, Perin T, De Paoli P, Maestro R, Buonadonna A.

Pathol Res Pract. 2016 Jan;212(1):63-7. doi: 10.1016/j.prp.2015.11.004. Epub 2015 Nov 10. Review.

PMID:
26616113
5.

Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST.

Brenca M, Rossi S, Polano M, Gasparotto D, Zanatta L, Racanelli D, Valori L, Lamon S, Dei Tos AP, Maestro R.

J Pathol. 2016 Mar;238(4):543-9. doi: 10.1002/path.4677. Epub 2016 Jan 25.

PMID:
26606880
6.

KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study.

Rossi S, Gasparotto D, Miceli R, Toffolatti L, Gallina G, Scaramel E, Marzotto A, Boscato E, Messerini L, Bearzi I, Mazzoleni G, Capella C, Arrigoni G, Sonzogni A, Sidoni A, Mariani L, Amore P, Gronchi A, Casali PG, Maestro R, Dei Tos AP.

Am J Surg Pathol. 2015 Jul;39(7):922-30. doi: 10.1097/PAS.0000000000000418.

PMID:
25970686
7.

Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor.

Gasparotto D, Rossi S, Campagna D, Scavina P, Tiziano FD, Marzotto A, Toffolatti L, Vitelli CE, Amini M, Dei Tos AP, Maestro R.

J Clin Oncol. 2016 Apr 10;34(11):e99-e103. doi: 10.1200/JCO.2012.44.7300. Epub 2014 Dec 29. No abstract available.

PMID:
25547508
8.

Improved outcome with multimodal treatment and imatinib rechallenge in advanced GIST.

Gasparotto D, Miolo G, Torrisi E, Canzonieri V, Bertola G, Libra M, Marzotto A, Maestro R, Buonadonna A.

Int J Colorectal Dis. 2014 May;29(5):639-40. doi: 10.1007/s00384-014-1838-6. Epub 2014 Feb 15. No abstract available.

PMID:
24525699
9.

IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas.

Martorelli D, Guidoboni M, De Re V, Muraro E, Turrini R, Merlo A, Pasini E, Caggiari L, Romagnoli L, Spina M, Mortarini R, Gasparotto D, Mazzucato M, Carbone A, Rosato A, Anichini A, Dolcetti R.

Clin Cancer Res. 2012 Aug 1;18(15):4080-91. doi: 10.1158/1078-0432.CCR-12-0763. Epub 2012 Jun 15.

10.

Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas.

Gasparotto D, Polesel J, Marzotto A, Colladel R, Piccinin S, Modena P, Grizzo A, Sulfaro S, Serraino D, Barzan L, Doglioni C, Maestro R.

Oncotarget. 2011 Dec;2(12):1165-75.

11.

Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size.

Rossi S, Gasparotto D, Toffolatti L, Pastrello C, Gallina G, Marzotto A, Sartor C, Barbareschi M, Cantaloni C, Messerini L, Bearzi I, Arrigoni G, Mazzoleni G, Fletcher JA, Casali PG, Talamini R, Maestro R, Dei Tos AP.

Am J Surg Pathol. 2010 Oct;34(10):1480-91. doi: 10.1097/PAS.0b013e3181ef7431. Erratum in: Am J Surg Pathol. 2011 May;35(5):781. Maestra, Roberta [corrected to Maestro, Roberta].

PMID:
20861712
12.

Multiple primary sporadic gastrointestinal stromal tumors in the adult: an underestimated entity.

Gasparotto D, Rossi S, Bearzi I, Doglioni C, Marzotto A, Hornick JL, Grizzo A, Sartor C, Mandolesi A, Sciot R, Debiec-Rychter M, Dei Tos AP, Maestro R.

Clin Cancer Res. 2008 Sep 15;14(18):5715-21. doi: 10.1158/1078-0432.CCR-08-0622. Epub 2008 Sep 8.

13.

Molecular approaches to the staging of head and neck carcinomas (review).

Gasparotto D, Maestro R.

Int J Oncol. 2007 Jul;31(1):175-80. Review.

PMID:
17549419
14.

Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.

Quartuccio L, De Re V, Fabris M, Marzotto A, Franzolini N, Gasparotto D, Caggiari L, Ferraccioli G, Scott CA, De Vita S.

Haematologica. 2006 May;91(5):691-4.

15.

HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations.

De Re V, Sansonno D, Simula MP, Caggiari L, Gasparotto D, Fabris M, Tucci FA, Racanelli V, Talamini R, Campagnolo M, Geremia S, Dammacco F, De Vita S.

Leukemia. 2006 Jun;20(6):1145-54.

PMID:
16617326
16.

A spindle cell variant of diffuse large B-cell lymphoma possesses genotypic and phenotypic markers characteristic of a germinal center B-cell origin.

Carbone A, Gloghini A, Libra M, Gasparotto D, Navolanic PM, Spina M, Tirelli U.

Mod Pathol. 2006 Feb;19(2):299-306.

17.

Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses.

De Re V, De Vita S, Sansonno D, Gasparotto D, Simula MP, Tucci FA, Marzotto A, Fabris M, Gloghini A, Carbone A, Dammacco F, Boiocchi M.

Rheumatology (Oxford). 2006 Jun;45(6):685-93. Epub 2006 Jan 6.

PMID:
16399842
18.

Hepatitis C virus (HCV) infection and lymphoproliferative disorders

Libra M, Gasparotto D, Gloghini A, Navolanic PM, De Re V, Carbone A.

Front Biosci. 2005 Sep 1;10:2460-71. Review.

PMID:
15970508
19.

Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection.

Libra M, Capello D, Gloghini A, Laura P, Berra E, Cerri M, Gasparotto D, Franca S, De Re V, Gaidano G, Carbone A.

J Pathol. 2005 May;206(1):87-91.

PMID:
15809970
20.

Aggressive forms of non-Hodgkin's lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses.

Libra M, Gloghini A, De Re V, Rupolo M, Navolanic PM, Gasparotto D, Stivala F, Spina M, Boiocchi M, Carbone A.

Int J Oncol. 2005 Apr;26(4):945-50.

PMID:
15753988
21.

Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection.

Libra M, De Re V, Gloghini A, Gasparotto D, Gragnani L, Navolanic PM, De Vita S, Mazzarino MC, Zignego AL, Carbone A, Boiocchi M.

Haematologica. 2004 Jul;89(7):873-4.

22.

Extrasalivary lymphoma development in Sjögren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering.

Gasparotto D, De Vita S, De Re V, Marzotto A, De Marchi G, Scott CA, Gloghini A, Ferraccioli G, Boiocchi M.

Arthritis Rheum. 2003 Nov;48(11):3181-6.

23.

Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue.

Libra M, De Re V, De Vita S, Gasparotto D, Gloghini A, Rupolo M, Degan M, Marzotto A, Stivala F, Carbone A, Boiocchi M.

Leukemia. 2003 Jul;17(7):1433-6. No abstract available.

PMID:
12835744
24.

Lack of HCV infection in malignant cells refutes the hypothesis of a direct transforming action of the virus in the pathogenesis of HCV-associated B-cell NHLs.

De Vita S, De Re V, Sansonno D, Gloghini A, Gasparotto D, Libra M, Sacco S, Carbone A, Ferraccioli G, Boiocchi M.

Tumori. 2002 Sep-Oct;88(5):400-6.

PMID:
12487559
25.

Differentiation between non-Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysis.

Libra M, De Re V, Gasparotto D, Gloghini A, Marzotto A, Milan I, Tirelli U, Stivala F, Carbone A, Boiocchi M.

Br J Haematol. 2002 Sep;118(3):809-12.

PMID:
12181049
26.

Hepatitis C virus, B-cell proliferation and lymphomas.

Gasparotto D, De Re V, Boiocchi M.

Leuk Lymphoma. 2002 Apr;43(4):747-51. Review.

PMID:
12153160
29.

Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process.

De Re V, De Vita S, Marzotto A, Gloghini A, Pivetta B, Gasparotto D, Cannizzaro R, Carbone A, Boiocchi M.

Int J Cancer. 2000 Jul 15;87(2):211-6.

30.

Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma.

De Vita S, De Re V, Gasparotto D, Ballarè M, Pivetta B, Ferraccioli G, Pileri S, Boiocchi M, Monteverde A.

Arthritis Rheum. 2000 Jan;43(1):94-102.

31.

Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis.

De Vita S, De Re V, Sansonno D, Sorrentino D, Corte RL, Pivetta B, Gasparotto D, Racanelli V, Marzotto A, Labombarda A, Gloghini A, Ferraccioli G, Monteverde A, Carbone A, Dammacco F, Boiocchi M.

Hepatology. 2000 Jan;31(1):182-9.

PMID:
10613744
32.

Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis.

Gasparotto D, Vukosavljevic T, Piccinin S, Barzan L, Sulfaro S, Armellin M, Boiocchi M, Maestro R.

Int J Cancer. 1999 Aug 20;84(4):432-6.

33.

Microsatellite instability in squamous cell carcinomas of the head and neck related to field cancerization phenomena.

Piccinin S, Gasparotto D, Vukosavljevic T, Barzan L, Sulfaro S, Maestro R, Boiocchi M.

Br J Cancer. 1998 Nov;78(9):1147-51.

34.

Overexpression of CDC25A and CDC25B in head and neck cancers.

Gasparotto D, Maestro R, Piccinin S, Vukosavljevic T, Barzan L, Sulfaro S, Boiocchi M.

Cancer Res. 1997 Jun 15;57(12):2366-8.

35.

Rarity of microsatellite genomic instability in B-cell non-Hodgkin's lymphomas in hepatitis C virus-infected patients.

De Vita S, Gasparotto D, Pivetta B, Vukosavljevic T, Zagonel V, Carbone A, Boiocchi M.

Br J Haematol. 1997 May;97(2):463-5.

PMID:
9163616
36.

Human non-Hodgkin's lymphomas overexpress a wild-type form of p53 which is a functional transcriptional activator of the cyclin-dependent kinase inhibitor p21.

Maestro R, Gloghini A, Doglioni C, Piccinin S, Vukosavljevic T, Gasparotto D, Carbone A, Boiocchi M.

Blood. 1997 Apr 1;89(7):2523-8.

37.

p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression.

Piccinin S, Doglioni C, Maestro R, Vukosavljevic T, Gasparotto D, D'Orazi C, Boiocchi M.

Int J Cancer. 1997 Feb 20;74(1):26-30.

38.

Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss.

Maestro R, Piccinin S, Doglioni C, Gasparotto D, Vukosavljevic T, Sulfaro S, Barzan L, Boiocchi M.

Cancer Res. 1996 Mar 1;56(5):1146-50.

39.

Recurrences and second primary tumours in the head and neck region: differentiation by p53 mutation analysis.

Gasparotto D, Maestro R, Barzan L, Vukosavljevic T, Doglioni C, Sulfaro S, Piccinin S, Boiocchi M.

Ann Oncol. 1995 Nov;6(9):933-9.

PMID:
8624298
40.

Spontaneous mutation of cell oncogenes plays a minor role in neoplastic transformation of virus-induced murine T-cell lymphomas.

Gasparotto D, Maestro R, Vukosavljevic T, Piccinin S, Sandrin A, Rizzo S, Boiocchi M.

Tumori. 1995 Jul-Aug;81(4):268-72.

PMID:
8540125
41.

MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas.

Maestro R, Gloghini A, Doglioni C, Gasparotto D, Vukosavljevic T, De Re V, Laurino L, Carbone A, Boiocchi M.

Blood. 1995 Jun 1;85(11):3239-46.

42.

Ultraviolet-induced p53 mutations in atypical fibroxanthoma.

Dei Tos AP, Maestro R, Doglioni C, Gasparotto D, Boiocchi M, Laurino L, Fletcher CD.

Am J Pathol. 1994 Jul;145(1):11-7.

43.

p53 protein over-expression and p53 gene abnormalities in HIV-1-related non-Hodgkin's lymphomas.

De Re V, Carbone A, De Vita S, Gloghini A, Maestro R, Gasparotto D, Vukosavljevic T, Boiocchi M.

Int J Cancer. 1994 Mar 1;56(5):662-7.

PMID:
8314342
44.

Three discrete regions of deletion at 3p in head and neck cancers.

Maestro R, Gasparotto D, Vukosavljevic T, Barzan L, Sulfaro S, Boiocchi M.

Cancer Res. 1993 Dec 1;53(23):5775-9.

45.

p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications.

Dolcetti R, Doglioni C, Maestro R, Gasparotto D, Barzan L, Pastore A, Romanelli M, Boiocchi M.

Int J Cancer. 1992 Sep 9;52(2):178-82.

PMID:
1521906
46.

High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx.

Maestro R, Dolcetti R, Gasparotto D, Doglioni C, Pelucchi S, Barzan L, Grandi E, Boiocchi M.

Oncogene. 1992 Jun;7(6):1159-66.

PMID:
1594246
47.

Adhesion molecule expression does not influence the leukemic behavior of murine T-cell lymphomas.

Dolcetti R, Maestro R, Gasparotto D, Rizzo S, Boiocchi M.

Leukemia. 1992;6 Suppl 3:101S-105S.

PMID:
1351121
48.

Triple helix formation by oligopurine-oligopyrimidine DNA fragments. Electrophoretic and thermodynamic behavior.

Manzini G, Xodo LE, Gasparotto D, Quadrifoglio F, van der Marel GA, van Boom JH.

J Mol Biol. 1990 Jun 20;213(4):833-43.

PMID:
2359124

Supplemental Content

Loading ...
Support Center